AAD Member

05/30/2026

Dermatology residents Benjamin Cooper, DO, Taha Rasul, MD, and Anthony Concilla, DO, created this new AAD Boards Fodder study chart that is "all about acne."

Learn how to manage cases from mild to severe, plus information on all the acne variants, including epidemiology, pathogenesis, clinical features, and treatment options.

Download the entire chart (plus dozens more!) in the AAD's Directions in Residency archive: https://www.aad.org/member/education/residents/fodder/pediatrics

05/28/2026

Get the latest on the Academy’s advocacy efforts from AADA President Murad Alam, MD, MSCI, MBA, FAAD, including updates on Medicare physician payment reform, superficial radiation therapy for non-melanoma skin cancers, and other key issues impacting dermatology.

Watch May 2026 updates from AADA President Murad Alam, MD, MSCI, MBA, FAAD, on Medicare physician payment reform, superficial radiation therapy for non-melanoma skin cancers, and more.

05/26/2026

An article published in JAAD evaluated the efficacy and safety of saturated saline immersion for treating refractory plantar warts over six months.

In this single-arm clinical trial, 17 patients were enrolled with plantar warts that failed standard treatments. The participants underwent daily 30-minute saturated saline immersion for eight weeks.

After the saturated saline immersion treatment, 98.3% of lesions cleared, and 88.2% of participants achieved complete remission at week eight compared to baseline. No recurrences occurred during the six-month follow-up.

Learn more in the AAD's - https://www.aad.org/dw/weekly/may-20-2026

05/25/2026

The Academy is now accepting applications for positions in councils, committees, and task forces (CCTFs). Member input is an essential part of the success of our organization, and being involved in CCTFs is a great way to make sure your knowledge and expertise impact our operations.

Learn more and submit your applications by May 31!

Log in to the American Academy of Dermatology.

05/22/2026

Yesterday, the American Academy of Dermatology Association hosted its annual AADA Capitol Hill Skin Cancer Check!

In total, the event welcomed more than 120 attendees, including seven Members of Congress, among them GOP Doc Caucus Co-Chair and AAD member Rep. John Joyce, MD, FAAD (R-PA), Dave Joyce (R-OH), Andrew Garbarino (R-NY), and Marcy Kaptur (D-OH).

This popular event provides a unique opportunity to offer free skin cancer checks to Members of Congress, congressional staff, and the public, while also promoting the specialty of dermatology and advocating for our sole congressional priority: Medicare physician payment reform.

05/21/2026

📢 AADA President Dr. Murad Alam was in Washington, D.C. for Medicare physician payment reform advocacy and political events on Capitol Hill.

Among his events, he had one-on-one meetings with fellow AADA member and Congressman Dr. John Joyce (R-PA), Dr. Kim Schrier (D-WA), and House Energy & Commerce Committee Chairman Brett Guthrie (R-KY) to thank them for their efforts and discuss the need to reform Medicare physician payment now.

05/15/2026

📢 AAD President Dr. Murad Alam wants to inspire dermatologists to apply for the AAD's councils, committees, and task forces (CCTF).

Applications are due at the end of the month. Visit aad.org/CCTF to learn how you can impact the future of dermatology through advocacy, education, research, and more.

05/14/2026

Level up your education with 2026 AAD Annual Meeting On-Demand!

Gain access to hundreds of recorded sessions from Denver — complete with audio and presentation slides — so you can revisit key insights, dive deeper into your favorite topics, or catch sessions you missed.

Plus, you can claim CME for the sessions you watch on-demand!

Learn more and pre-order today: https://www.aad.org/member/meetings-education/on-demand-sessions

05/13/2026

A study published in the Journal of Cosmetic Dermatology explored the efficacy and safety of oral spironolactone for women with acne.

Overall, five randomized controlled trials consisting of 563 patients were included in the analysis. Acne severity was classified as either mild to severe, moderate to severe, severe, or not reported. The doses ranged from 25 mg to 200 mg daily.

The analysis showed a sixfold greater improvement in acne in the spironolactone group versus the placebo group (odds ratio, 6.59).

Among patients receiving spironolactone compared with those receiving placebo, nonsignificant adverse events included breast enlargement in 14.9% and 11.3% and menstrual irregularities in 18.1% and 20.4% of the groups, respectively.

Learn more in : https://www.aad.org/dw/weekly/april-08-2026

05/12/2026

What is the most likely diagnosis? 👀 A man in his 60s with a multiple history of cardiac sarcoidosis and chronic renal failure being treated with prednisone and mycophenolate mofetil is admitted to the hospital for weakness and a fall.

He noticed a new rash on his right forearm that started about 3 days ago as a flat pink patch that turned into a large plaque with drainage. The lesion is itchy but otherwise asymptomatic. A skin biopsy is performed, and the findings are shown in Figure 2 and Figure 3.

A. Blastomycosis
B. Eumycetoma
C. Hyalohyphomycosis
D. Lobomycosis
E. Phaeohyphomycosis

Submit your answer for CME credit! ➡️ https://bit.ly/4fhz4sJ